Clinical Trial Update: Inhaled Oxytocin and HPA Axis Reactivity [Phase 2]

View source ↗

Summary

Phase 2 trial of inhaled oxytocin evaluating HPA axis reactivity in postpartum depression, major depressive disorder, and anxiety disorders has completed, with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety Disorders
• Major Depressive Disorder
• Postpartum Depression

Drugs mentioned

• Inhaled oxytocin (Oxytocin)

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Depression, Postpartum, Anxiety Disorders | Phase 2 | Status: COMPLETED | Results posted: 2024-05-24